High-Risk Basal Cell Carcinomas of the Head and Neck: Selected Successful Surgical Approach in Three Bulgarian Patients!
Advancement flap
Island flap
Treatment outcome
Undermining surgical approach
Journal
Open access Macedonian journal of medical sciences
ISSN: 1857-9655
Titre abrégé: Open Access Maced J Med Sci
Pays: North Macedonia
ID NLM: 101662294
Informations de publication
Date de publication:
31 May 2019
31 May 2019
Historique:
received:
17
04
2019
revised:
18
05
2019
accepted:
26
05
2019
entrez:
19
6
2019
pubmed:
19
6
2019
medline:
19
6
2019
Statut:
epublish
Résumé
Regarding localisation, basal cell carcinomas are classified in three risk groups, designated as H for high-, M as medium-, and L as low-risk area. In patients with high-risk basal cell carcinomas (BCCs), as a first-line of treatment are mentioned, different types of surgical approaches and radiotherapy. Depending on the location of the tumour, the choice of surgical technique should vary and be consistent with the patient's will for a most aesthetically acceptable result. Three cases of patients with BCCs defined as high-risk about two different indicators-localisation and relapse after radiation therapy are presented. For the recovery of the occurred defects, three different types of surgical approaches (primary closure/undermining surgical approach, island flap and advancement flap) were used, tailored to the high-risk factors in each patient, which at the same time provided a perfect clinical outcome. High-risk BCCs are a challenge for every dermatosurgeon and require serious training and knowledge both in terms of anatomy and in terms of the possibilities for reconstruction of the defects that occurred. Operations usually run in three phases, namely: 1) removal of tumour tissue, 2) intraoperative plan for reconstruction according to the size of the defect and the condition of the surrounding tissues as well as phase 3) undermining of surrounding tissues and adaptation of the wound edges.
Sections du résumé
BACKGROUND
BACKGROUND
Regarding localisation, basal cell carcinomas are classified in three risk groups, designated as H for high-, M as medium-, and L as low-risk area. In patients with high-risk basal cell carcinomas (BCCs), as a first-line of treatment are mentioned, different types of surgical approaches and radiotherapy. Depending on the location of the tumour, the choice of surgical technique should vary and be consistent with the patient's will for a most aesthetically acceptable result.
CASE REPORT
METHODS
Three cases of patients with BCCs defined as high-risk about two different indicators-localisation and relapse after radiation therapy are presented. For the recovery of the occurred defects, three different types of surgical approaches (primary closure/undermining surgical approach, island flap and advancement flap) were used, tailored to the high-risk factors in each patient, which at the same time provided a perfect clinical outcome.
CONCLUSIONS
CONCLUSIONS
High-risk BCCs are a challenge for every dermatosurgeon and require serious training and knowledge both in terms of anatomy and in terms of the possibilities for reconstruction of the defects that occurred. Operations usually run in three phases, namely: 1) removal of tumour tissue, 2) intraoperative plan for reconstruction according to the size of the defect and the condition of the surrounding tissues as well as phase 3) undermining of surrounding tissues and adaptation of the wound edges.
Identifiants
pubmed: 31210819
doi: 10.3889/oamjms.2019.360
pii: OAMJMS-7-1665
pmc: PMC6560301
doi:
Types de publication
Case Reports
Langues
eng
Pagination
1665-1668Références
Clin Anat. 2013 Mar;26(2):183-95
pubmed: 22887451
Arch Plast Surg. 2013 Jul;40(4):387-91
pubmed: 23898436
J Cutan Aesthet Surg. 2014 Jul;7(3):143-50
pubmed: 25538434
Med Arch. 2013 Dec;67(6):450-3
pubmed: 25568520
Clin Transl Oncol. 2015 Jul;17(7):497-503
pubmed: 25643667
An Bras Dermatol. 2015 May-Jun;90(3):377-83
pubmed: 26131869
Int J Clin Exp Pathol. 2015 Nov 01;8(11):15448-53
pubmed: 26823913
Med J Aust. 1997 Jun 2;166(11):581-3
pubmed: 9201177